The usual degeneration of discussion. And contrary to our...

The usual degeneration of discussion. And contrary to our resident expert, donor reliant stem cell procedures very much have pressing problems even at this low demand:

https://www.abc.net.au/news/2023-03-17/stem-cell-shortage-cancer/102109166

and equally have long been pressing shortages in the USA for bone marrow donor area, even in well established protocols.

https://newsnetwork.mayoclinic.org/discussion/the-growing-need-for-bone-marrow-donors/

(shouting one's opinion loudly, does not make it fact, whilst reporting of evidence may indicate pressing trends/issues - MSB [I am a holder] will itself readily admit its scaling and consistency issues vs IPSC, but has gone a long way to address, but just like VHS ousted Betamax, the Ipod the Walkman, IPSC's will likely eventually naturally oust donor based allogeneic stem cell treatments and maybe MSB will look to embrace the technology itself via an eventual amalgamation)